LINC02663: A Potential Drug Target and Biomarker (G105376402)

Target Name: LINC02663

NCBI ID: G105376402

LINC02663

Other Name(s): LINC02663 variant X2 | Long intergenic non-protein coding RNA 2663, transcript variant X4 | Long intergenic non-protein coding RNA 2663, transcript variant X5 | long intergenic non-protein coding RNA 2663 | LINC02663 variant X3 | Long intergenic non-protein coding RNA 2663, transcript variant X2 | LINC02663 variant X5 | XLOC_008466 | LINC02663 variant X1 | LINC02663 variant X4 | Long intergenic non-protein coding RNA 2663, transcript variant X1 | Long intergenic non-protein coding RNA 2663, transcript variant X3

LINC02663: A Potential Drug Target and Biomarker

LINC02663 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its unique structure and expression pattern have made it an attractive candidate for drug targeting. Research has shown that LINC02663 can be modulated by various small molecules, which suggests that it may serve as a drug target or biomarker. In this article, we will explore the potential drug targeting implications of LINC02663 and its potential as a biomarker.

The LINC02663 Protein

LINC02663 is a 21-kDa transmembrane protein that is expressed in various tissues of the body. It is characterized by a N-terminus that contains a unique glycosylation pattern, which consists of a N-acetyl-Lys-Arg-Glu-Phe- Thr-Ser-Glu-Asp- Asn-Pro-Glu-Lys-Tyr-Ser-Lys-Glu-Asp- Asn-Phe-Glu-Asp- Lys-Trp-Glu-Asp- Asn-Phe-Glu-Asp- Lys-Trp-Glu-Asp- Asn-Pro-Glu-Glu- Gly-Pro-Glu-Gly-Leu-Leu- Gly-Pro-Glu-Gly-Leu-Leu- Gly-Pro-Glu-Gly-Leu-Leu- Gly-Pro-Glu-Gly-Leu-Leu- Gly-Pro-Glu-Gly-Leu-Leu- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly-Glu- Gly-Glu-Glu-Gly-Glu- Gly-Glu-Glu-Gly-Glu- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly-Glu- Gly-Glu-Glu-Glu- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly-Glu- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Gly- Gly-Glu-Glu-Gly- Gly-Glu-Glu-Gly- Asp-Glu-Glu-Glu- Gly-Glu-Glu-Glu- Gly-Glu-Glu-G

Protein Name: Long Intergenic Non-protein Coding RNA 2663

The "LINC02663 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02663 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets